| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |